SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Cipla Seen Reporting Muted Q2 as Revlimid Drag Weighs

Cipla is expected to report a muted second quarter, with Revlimid weighing on results.

Related stories